Sheila Ramjug
Sheila Ramjug is a Consultant Pulmonologist with a specialist
interest in pulmonary vascular and interstitial lung disease,
working in Wythenshawe Hospital, Manchester University NHS
Foundation Trust (Manchester, UK).
She obtained her first consultant position at the start of the
COVID-19 pandemic and due to her previous cardiothoracic
intensive care experience, she initially worked in the COVID-19
intensive care unit, after which she transitioned to care for
patients on the acute COVID-19 wards. During this time, Sheila
had the opportunity to develop local venous thromboembolism
guidance in COVID-19 in relation to national and international
standards, as well as reviewing discharged COVID-19 patients
with evidence of venous thromboembolism.
Sheila is part of the ERS Monograph editorial board as the
previous early career member representative for the Pulmonary
Vascular Disease Assembly of the European Respiratory Society.
viii https://doi.org/10.1183/2312508X.10016621
Sheila Ramjug is a Consultant Pulmonologist with a specialist
interest in pulmonary vascular and interstitial lung disease,
working in Wythenshawe Hospital, Manchester University NHS
Foundation Trust (Manchester, UK).
She obtained her first consultant position at the start of the
COVID-19 pandemic and due to her previous cardiothoracic
intensive care experience, she initially worked in the COVID-19
intensive care unit, after which she transitioned to care for
patients on the acute COVID-19 wards. During this time, Sheila
had the opportunity to develop local venous thromboembolism
guidance in COVID-19 in relation to national and international
standards, as well as reviewing discharged COVID-19 patients
with evidence of venous thromboembolism.
Sheila is part of the ERS Monograph editorial board as the
previous early career member representative for the Pulmonary
Vascular Disease Assembly of the European Respiratory Society.
viii https://doi.org/10.1183/2312508X.10016621